← Back to Search

Behavioral Intervention

Mobile App Support for HIV (VSS Trial)

N/A
Waitlist Available
Led By Jorge A Montoya, PhD
Research Sponsored by Sentient Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recently diagnosed with HIV (within 12 months), diagnosed but not in care, or in care but not virally suppressed (viral load ≥200 copies/mL)
MSM
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if a mobile app called Amp can help young black men who have sex with men and are living with HIV improve their health outcomes. The trial will compare the outcomes of those who

Who is the study for?
This trial is for young Black men who have sex with men (YBMSM) living with HIV. Participants should be willing to use the Amp mHealth app along with their standard HIV care and will be compared to those receiving only standard care.
What is being tested?
The study is testing the effectiveness of an mHealth app called Amp, designed to help manage HIV treatment outcomes. Over a period of 5 months, researchers will compare health measures between two groups: one using Amp plus standard care and another receiving just the standard care.
What are the potential side effects?
Since this trial involves an mHealth app rather than medication, traditional side effects are not applicable. However, participants may experience issues related to privacy concerns or stress from constant health monitoring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with HIV less than a year ago, or I am not virally suppressed.
Select...
I am a man who has sex with men.
Select...
I am between 18 and 29 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIV Stigma
Viral Suppression
Secondary study objectives
Adherence barriers
Anti-retroviral medication adherence
Anxiety symptoms
+13 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Amp mHealth AppExperimental Treatment1 Intervention
Amp, video-based, virtual support system on an mHealth platform with resources and tools to help YBMSM living with HIV become and stay virally suppressed.
Group II: Standard of CareActive Control1 Intervention
Standard of care (SOS) linkage to care services typically provided by linkage specialists, health navigators, or case workers.

Find a Location

Who is running the clinical trial?

University of Mississippi Medical CenterOTHER
180 Previous Clinical Trials
196,591 Total Patients Enrolled
Wayne State UniversityOTHER
314 Previous Clinical Trials
110,597 Total Patients Enrolled
Los Angeles LGBT CenterOTHER
6 Previous Clinical Trials
1,162 Total Patients Enrolled
Sentient ResearchLead Sponsor
2 Previous Clinical Trials
5,773 Total Patients Enrolled
AIDS Healthcare FoundationOTHER
18 Previous Clinical Trials
146,271 Total Patients Enrolled
Jorge A Montoya, PhDPrincipal InvestigatorSentient Research
~189 spots leftby Dec 2025